Screening for nonalcoholic fatty liver disease-when, who and how?

Nonalcoholic fatty liver disease (NAFLD) is becoming a frequent liver disease, especially in patients with metabolic syndrome and especially in Western countries. Complications of NAFLD comprise progressive fibrosis, cirrhosis and hepatocellular carcinoma. NAFLD also represents an independent risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietrich, Christoph G, Rau, Monika, Geier, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475001/
https://www.ncbi.nlm.nih.gov/pubmed/34629804
http://dx.doi.org/10.3748/wjg.v27.i35.5803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475001/
https://www.ncbi.nlm.nih.gov/pubmed/34629804
http://dx.doi.org/10.3748/wjg.v27.i35.5803

Ejemplares similares